Researchers at Western University and Lawson Health Research Institute are using tobacco plants as ‘green bioreactors’ to produce an anti-inflammatory protein with powerful therapeutic potential.
The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.
“This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases,” said Dr. Tony Jevnikar, Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson. “The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury.”
And while showing promise in animal models, IL-37’s use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.
That’s where the tobacco plants come in.
This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. “The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods,” said Shengwu Ma, PhD, Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. “Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks.”
The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they’ve shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.
Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.
“I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable,” Dr. Jevnikar said.
The Latest on: Green bioreactors
via Google News
The Latest on: Green bioreactors
- Tucson Tech: UA tech spinoff aims to make algae for nutraceuticalson April 9, 2021 at 11:00 am
A Tucson startup has licensed technology invented by a University of Arizona professor to grow algae for drugs, nutritional supplements and other uses.
- The Hidden Story Behind Tampa’s Toxic Poolon April 9, 2021 at 6:04 am
Our agricultural system shares a deep structural similarity to the command economy of Joseph Stalin's Soviet Union. Considering how spectacularly all command economies fail, why do we expect one to ...
- Government of Canada announces over $5M in clean tech funding for British Columbia Fisheries and Aquaculture Projectson April 7, 2021 at 2:00 pm
The Fisheries and Aquaculture Clean Technologies Adoption Program is a federal initiative encouraging the adoption of green technologies ... and install algae bioreactors which will reduce energy ...
- Outlook on the Single-Use Bioreactors Global Market to 2030 - Featuring Cytiva, Merck Millipore & Pall Among Otherson April 6, 2021 at 10:33 am
12.5. Global Single-Use Bioreactors Market: Distribution by Type of Cell Culture 12.6. Global Single-Use Bioreactors Market: Distribution by Type of Molecule 12.7. Global Single-Use Bioreactors ...
- Internships nurture future talenton April 3, 2021 at 5:00 pm
“I worked in HKPC’s Green Living & Innovation Division ... from working in the lab and doing some chemical quick tests to monitor the status of the bioreactors.” Miss Chan attained valuable advice ...
- Ecovative gets new round of $60 million in fundingon April 2, 2021 at 9:05 am
GREEN ISLAND — Ecovative ... Utilizing proprietary bioreactors and workflows, Ecovative produces high-performance materials for textiles as well as food and packaging, while maintaining a ...
- A Canadian company challenges vaccine rules to increase accesson April 1, 2021 at 1:43 pm
We have large bioreactors here that could deal with an ... or if they do get the green light, how long it will then take to manufacture and gain approval for their version.
- Global Single-Use Bioreactors Market (2020 to 2030) - by Type of Reactor, Cell Culture System, End-user, and Geographyon April 1, 2021 at 2:46 am
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Single-Use Bioreactors Market by Type of Reactor, Cell Culture System, End-User, and Geography: Industry Trends and Global Forecasts, 2020-2030" report ...
via Bing News